Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479128
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-03
First Post:
2007-05-24
Brief Title:
Bortezomib with GemcitabineDoxorubicin in Patients with Urothelial Cancer and Other Solid Tumors
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Urethral Cancer |
| Solid Tumor |
Keywords:
| Name | View |
|---|---|
| Hydroxydaunomycin hydrochloride | View |
| Solid Tumor | View |
| Bladder Cancer | View |
| Ureteral Cancer | View |
| Urothelial Cancer | View |
| Urethral Cancer | View |
| Renal Pelvis Tumor | View |
| Bortezomib | View |
| Gemcitabine | View |
| Doxorubicin | View |
| Gemzar | View |
| Adriamycin | View |
| Velcade | View |
| LDP-341 | View |
| MLN341 | View |
| PS-341 | View |
| Gemcitabine Hydrochloride | View |
| AD | View |